Advancing new therapeutic possibilities to address unmet need

Our ProXiMATE™ engine provides unparalleled insight into proximity biology that enables a differentiated pipeline with both First- and Best-In-Class potential.  InduPro is rapidly advancing programs in oncology and immunology by harnessing novel proximity-based modalities.

Therapeutic ApproachProgramClassIndicationLead DiscoveryLead OptimizationPre-clinical in vivo efficacyIND enabling studies
Tumor Associated Proximity Antigen (TAPA)
IDP-001 TAPA-ADC Oncology Multiple Cancers

 
IDP-001 TAPA-TCE Oncology Multiple Cancers

 
Synapse Modulation
IDP-002 Sequestration Immuno-Oncology

 
IDP-003 Recruitment/Agonism Autoimmune disease

 
Discovery
Discovery Multiple Several

 
Tumor Associated Proximity Antigen (TAPA)
Lead DiscoveryLead OptimizationPre-clinical in vivo efficacyIND enabling studies
IDP-001
Class: TAPA-ADC
Indication: Oncology Multiple Cancers
IDP-001
Class: TAPA-TCE
Indication: Oncology Multiple Cancers
Synapse Modulation
Lead DiscoveryLead OptimizationPre-clinical in vivo efficacyIND enabling studies
IDP-002
Class: Sequestration
Indication: Immuno-Oncology
IDP-003
Class: Recruitment/Agonism
Indication: Autoimmune disease
Discovery
Lead DiscoveryLead OptimizationPre-clinical in vivo efficacyIND enabling studies
Discovery
Class: Multiple
Indication: Several